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ABSTRACT

THE POSTOPERATIVE INCIDENCE OF SMALL BOWEL OBSTRUCTION FOLLOWING
VARIOUS ABDOMINAL PROCEDURES: A SIX YEAR RETROSPECTIVE COHORT
STUDY AT YALE-NEW HAVEN HOSPITAL. Ross I.S. Zbar (Sponsored by Charles F.
McKhann). Department of Surgery, Yale University School of Medicine, New Haven, CT.

Postoperative adhesions are the most common cause of small bowel obstruction (SBO) in
the United States. The Kaplan-Meier product-limit method was used to tabulate incidence rates
of SBO in a retrospective, longitudinal cohort study of all patients at Yale-New Haven Hospital
who underwent any one of nine abdominal procedures from September 30, 1985 to October 1,
1986, and who returned for follow-up during the ensuing six years.

Furthermore, a

descriptive analysis of all patients who underwent any one of 77 abdominal surgeries and then
presented with SBO was reviewed. Analysis revealed the following incidence rates: Duhamel
procedure, 66.7% obstruction during 36 months of follow-up (n=3); Colostomy, 30.8%
during 69 months (n=34); Total abdominal hysterectomy, 18.2% during 70 months (n=121);
Abdominoperineal resection, 14.3% during 53 months (n=9); Splenectomy, 11.2% during 65
months (n=2Q); Appendectomy, 10.7% during 64 months (n=41); Cholecystectomy, 6.4%
during 67 months (n=141); Vaginal hystectomy, 0.0% during 70 months (n=15); and
Gastroenterostomy 0.0% after 11 months (n=8). (Overall, Breslow-Cox p < 0.00005). An inhospital mortality of 0.0% among obstructed patients was noted. Obstructed cancer patients
(n=26) and obstructed cancer-free patients (n=32) differed in average age (62.8 years and 47.3
years, respectively, p < 0.005) and average total hours of surgery since entering the cohort
(3.5 hours and 2.6 hours, respectively, p < 0.0005). Cancer patients who presented with
obstruction required significantly more surgical procedures since entering the cohort
(p=0.025), whereas differences in the total number of abdominal surgeries prior to entering the

cohort and the average duration of hospitalization for the treatment of SBO were not
significant.

This is the first study which utilizes Kaplan-Meier product-limit analysis to

calculate specific incidences of obstruction for various abdominal operative procedures.
Characterization of obstructed cancer patients and obstructed cancer-free patients demonstrated
significant differences between these two groups.

TABLE OF CONTENTS

Introduction
History of Intestinal Obstruction
Changing Etiology of Intestinal Obstruction
Postoperative Adhesion Formation
Symptoms of Small Bowel Obstruction
Pathophysiology of Small Bowel Obstruction
Early versus Delayed Small Bowel Obstruction
Previous Studies of SBO After Abdominal Surgery
Previous Attempts to Derive an Incidence of SBO After Surgery
Purpose of the Present Study
Design of the Present Study

1
2
5
6
9
9
10
11
12
13
14

Materials and Methods
Cohort Parameters
Statistical Analysis
Follow-Up Data
Incidence Density
Technical Assistance

17
17
19
20
21
21

Results

22
22
25
25

Kaplan-Meier Product-Limit Analysis
Statistical Analysis of Kaplan-Meier Incidence Curves
Descriptive Analysis

Discussion
Strengths of Kaplan-Meier Methodology
Rates of Obstruction Vary with Abdominal Procedure
Potential Shortcomings of the Kaplan-Meier Methodology
Descriptive Analysis of Obstructed Patients
Conclusions

30
30
31
38
42
47

Figures

50

Tables

55

References

73

1

INTRODUCTION

Small bowel obstruction (SBO) is a pathological condition which causes severe
morbidity and significant mortality. This condition occurs when the intestinal contents are
prevented from moving along the length of the intestine. There are two categories of small
bowel obstruction: mechanical and neurogenic.

Mechanical SBO is due to physical

occlusion, either external or internal, of the gastrointestinal lumen. A simple, mechanical
obstruction occurs when only the intestinal contents are blocked; whereas a strangulated,
mechanical obstruction occurs when both the intestinal contents and the intestinal blood
supply are halted. Neurogenic SBO (also known as adynamic ileus) results from intestinal
paralysis.
Common pathophysiologic mechanisms leading to physical obstruction of the small
bowel include postoperative adhesions, internal hernia, external hernia, congenital bands,
postinflammatory adhesions, inflammatory bowel disease and carcinoma. Less common
causes are foreign bodies (including gallstones, parasites, fecaliths, enteroliths,
concretions, bezoars, food boli and meconium), intussusception and tuberculosis.
Carcinoma, diverticulitis and volvulus are major mechanisms of large bowel obstruction.
Etiologic agents of neurogenic intestinal obstruction include peritoneal insult, electrolyte
disturbances (especially hypokalemia), retroperitoneal hematomas, ureteral calculi, severe
pyelonephritis, lower-lobe pneumonia, myocardial infarction, fractured ribs and
neurological disorders (including CNS trauma and severed spinal cord).3'11-12-^
Although postoperative adhesions are currently the most common cause of small bowel
obstruction in the United States, surprisingly few studies have specifically examined
postoperative patients for subsequent small bowel obstruction. The present study applies
Kaplan-Meier product-limit analysis to calculate the true, at-risk incidence of small bowel
obstruction for a cohort of patients following various abdominal surgical procedures.
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Additionally, a descriptive analysis of co lort patients who present with obstruction is
undertaken in order to reveal any underlying characteristics within this group.

History of Intestinal Obstruction

The earliest documented case of intestinal obstruction dates from the third century BC.
To treat this patient, the Greek physician Praxagoras undertook surgical intervention by:

"[makingl an incision over the [abdominal] swelling of a
strangulated hernia in the inguinal area [and then] freeing the
gut and cutting into the large bowel to establish an artifical
anus."49

This ancient account does not describe how the patient recovered, or if in fact, he recovered
at all. Additionally, this is an isolated account, for invasive abdominal surgery was rarely
undertaken in the ancient world.
More common was the medical treatment recommended by Hippocrates, who prescribed
"inflation of the rectum [with water] by means of a bladder attached to a pipe."49 This
treatment of obstruction - with enemas - continued actively until the late nineteenth century.
Generally, the ancient world considered intestinal obstruction a fatal condition. In the
first century AD, the Roman medical author Celsus, wrote:

"In ileus, it is pain which kills, along with inflammation of
the bowel or straining and swelling. A most acute and most
disgusting form of death...[Tlhose in ileus, from excess of
pain, earnestly desire death. The physician therefore, must
neither be inferior to the infection nor more dilatory; but, if
he finds inflammation to be the cause, open a vein at the
elbow by a large orifice, so that the blood...may flow
copiously...for this is...the commencement of an escape
from pain."11
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Throughout the Byzantine and Renaissance eras, the medical treatments for intestinal
obstruction as outlined by Hippocrates and Celsus continued with little modification. In the
sixteenth century, Ambroise Pare recommended rectal enemas and powdered wolf gut. In
severe cases of obstruction, Pare was known to give bullets smeared with mercury for
patients to swallow.11 In the same century, Marianus Sanctus wrote of orally
administering three pounds of mercury to a patient with obstruction and then rolling him on
the ground.49
Noninvasive therapy for bowel obstruction generally remained unsuccessful.
Woodhall, in 1639, wrote:

"So many which are oppressed with this disease doe perish,
and dies a very miserable death, ending their daies with their
feyces of their owne excrements issuing out of their
mouthes."11

In 1676, Sydenham added opium to the pharmaceutical armamentarium. The opium not
only calmed the patient, by decreasing the pain, but also decreased intestinal motility and
occasionally helped patients recover. Sydenham felt strongly that the opium had a better
therapeutic effect when administered with a live kitten on the patient's abdomen.49 This
treatment was to remain popular for two centuries.
The late seventeenth century also marked the beginning of abdominal paracentesis. This
treatment, although considered dangerous, was used as a last resort in all types of
abdominal distension, including obstruction.11 This method of treatment lasted for two
hundred years, for Blake and Bigelow reported using percutaneous intestinal puncture for
the treatment of intestinal obstruction in Boston as late as 1876 49
There were scattered reports of the surgical treatment of bowel obstruction during the
late Renaissance and Enlightenment periods. In 1561, Franco operated on a strangulated
hernia by making an incision over the swelling and cutting the constricting band.49
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Bonetus described the successful reduction of an intussusception through surgical
management in 1679.11

With the founding of the French Royal Academy of Surgery in

1731 by La Peyronie and Mareschal, the exchange and study of surgical techniques
involving the bowel became popular. One surgeon reported that he excised gangrenous
bowel and created an artifical anus in a woman with a strangulated hernia as early as 1701.
La Peyronie stated that he opened the peritoneal cavity to treat a case of intestinal
obstruction. In 1740, Pipelet reported the excision of several inches of dead bowel and the
creation of an artificial anus to treat an incarcerated hernia.49 Pillore of Rouen performed
the first intraperitoneal cecostomy with a rubber enema pipe in 1776 to relieve
obstruction.11 Yet despite these well documented case reports, the surgical treatment of
intestinal obstruction did not make a lasting impression upon surgeons outside of France.
Furthermore, with the French revolution, the Royal Academy was dissolved.
For some time, electrical stimulation became the popular treatment. This involved
completing an electrical circuit between the patient's rectum and the abdominal wall as
reported by L'Etoille in 1826.49 Forty years later, Kussmaul suggested the use of gastric
lavage to wash out the "intestinal toxins."49 Nevertheless, despite all of these treatments,
intestinal obstruction remained highly fatal. In the 1880s, Furbringer wrote:

"The medical management of intestinal obstruction is not so
bad, nor the results of surgery not so good, as to warrant
calling in the surgeon."49

However, it was Frederick Treves of London Hospital in 1899 who began promoting
the modem surgical management of bowel obstruction. Treves wrote: "It is less dangerous
to leap from the Clifton Suspension Bridge than suffer from acute intestinal obstruction and
decline operation."49 Although his viewpoint was initially met with resistance, physicians
slowly adopted a surgical approach to obstruction at the turn of the century.
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With the development of the gastroduodenal tube in the early twentieth century, a new
era dawned in the treatment of intestinal obstruction. The intestinal tube was developed
from the already existing stomach tube. The first use of a stomach tube was recorded by
Hunter in 1790 to treat a patient with achalasia. This tube was made of eelskin.50 Then in
1910, Gross and Eihom developed nasogastric tubes with weighted metal tips. The Levin
nasogastric tube was a 1921 development, which lacked the metal tip. However, it was
Wangensteen who in 1931 applied suction to an indwelling intestinal tube and
decompressed three acute intestinal obstructions. Wangensteen's intestinal tube underwent
several modifications. In the late 1930s, Miller and Abbott made a double lumen, rubber
tube with an air filled balloon tip. Johnston designed an intestinal tube with a larger lumen
and Dennis created a tube with three lumens. In 1946, Cantor introduced a single lumen
tube with a greater inner diameter and with more holes in the tip. Additionally, the tip was
loaded down with a mercury filled balloon.50 Although Wangensteen recognized the need
for early operative intervention in patients with either intestinal strangulation or failed
intestinal tube therapy, the long tube was abused in the late 1940s with many patients
developing perforation or gangrenous bowel.9 By the end of the 1950s, however, the
appropriate indications for conservative intestinal tube therapy became well defined. These
indications are discussed later.

Changing Etiology of Intestinal Obstruction

Careful review of studies reported over the last century demonstrates a changing
etiology of intestinal obstruction in the Western World. As surgical attitudes have changed
about entering the abdomen, so have the nature of intestinal obstructions.
Table I lists many of the major studies conducted during the past 100 years concerning
intestinal obstruction and its etiology.

An interesting trend emerges: The percent of

obstructions caused by hernias has decreased, while the percent of obstructions caused by
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postoperative adhesions has increased. This is due to both the earlier repair of hernias by
Western surgeons, as well as, an increase in the number of abdominal procedures
performed which generate postoperative adhesions.6
The presence of adhesive bands in patients with bowel obstruction, even in the absence
of previous surgery, is demonstrated in several studies.11’12’38-39

The percent of

obstructions caused by these adhesions in nonsurgical patients varies, but is generally
between 5% to 15%.11 Such bands are congenital or secondary to previous episodes of
inflammation.
Of further interest is the current etiology of intestinal obstruction in developing
countries, which is similar to that of England and the United States at the turn of the
century. Chakrabarty illustrated this in his study from India, conducted from 1968 through
1974, which revealed strangulated external hernia to be the most common etiology of
intestinal obstruction.12 This finding was due to both the higher rate of untreated hernias
which were allowed to progress to strangulation or obstruction, as well as, the lower rate
of laparotomy in developing countries.
Nevertheless, today, postoperative adhesions are the most common cause of bowel
obstruction in the United States.

Postoperative Adhesion Formation

The underlying pathophysiology of postoperative adhesion formation is not well
understood. In 1843, Samuel Gross was the first to make the experimental observation of
adhesion genesis. He noted that after suturing intestinal wounds in dogs, there followed an
attachment of omentum to the surface and edges of the wound.15 In the early twentieth
century, adhesions in postoperative patients were observed to form between bowel,
incision, abdominal wall and drain site. Adhesions were also commonly present after

*v
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sepsis, anastomotic leak or peritonitis. The structure most commonly involved was the
omentum, followed by the ileum and the jejunum.50
From the above observations, surgeons felt that mechanical trauma to the intestine was
the sole component necessary for adhesion genesis.

A 1935 textbook described the

adhesion process as:

"hyperemia and edema of inflamed serosa, [followed by]
rapid deposition of fibrin. Involved surfaces [then] adhere
together. This fibrous network may absorb within a few
days. In other cases organization may occur with the growth
of blood vessels and fibroblasts [and] development of
fibrous adhesions."15

Although the histiological description is accurate, surgeons incorrectly assumed that fibrin
deposition would occur only if the serosal vascular network was not intact, therefore
preventing reabsorption of fibrous exudate. Damage of the vascular network - through
mechanical trauma, retraction, surgical denudement - was equated with adhesion formation.
This proved to be only part of the answer, for in 1955, Williams demonstrated that
abrasion of the parietal peritoneum in rabbits did not necessarily lead to adhesions.51 A
similar experiment was performed by Dembowski in 1888, but unfortunately, it had been
largely ignored.15 However, it was Ellis who finally accounted for these observations by
proposing the ischemic vascular model of adhesion formation. This model postulated that
vascular in-growth occurs toward ischemic peritoneal tissues. Then, with the ischemic
crisis over, the vascular collateral channels reabsorb and leave a fibrous matrix.16 Thus the
fibrous adhesions represent "vascular grafts" to ischemic areas in the peritoneal cavity.
Ellis successfully supported his hypothesis by tying off mesenteric arteries in controlled
experiments with rats.16 Also of note is the work of Belzer, who demonstrated that venous
congestion, with intact lymphatic flow, promoted extensive adhesion formation.2

8

Buckman showed that deperitonealized tissue has a high fibrinolytic activity which
ischemic tissue lacks.10 Thus reperitonealizing the abdomen with sutured peritoneum,
which is itself ischemic, in fact promotes adhesion formation.
Other factors associated with adhesion formation include foreign body granulomas. In
particular, talc (magnesium silicate), which was formerly used as a surgical glove lubricant,
produces a severe foreign body reaction and granuloma formation.31 Gauze lint, suture
filament and anti-microbial solutions have also been implicated in the formation of
granulomas which promote adhesions.50 Although the current surgical glove lubricant,
starch, is absorbed within four weeks and supposedly does not produce foreign body
reactions, there have been reported cases of large, intra-abdominal starch particles
promoting granulomas.50
Chemical irritation of the peritoneum is associated with adhesion formation. This
includes peritoneal infection, whether localized or generalized, pooled blood and spillage of
gastrointestinal tract contents.31
Thermal injury is another avenue for adhesion formation.

There is evidence that

laparotomy pads, which are either too hot or too cold, can generate enough tissue damage
to promote adhesion formation.31
The actual connection between adhesion formation and intestinal obstruction is
straightforward. By tacking the bowel in place, the adhesions can promote bowel to kink
or wrap. Additionally, adhesions can form constricting bands which contract with time.
Surgeons have tried experimentally to limit adhesion formation, despite the many
different mechanisms involved. Attempts to remove fibrin exudate with proteolytic
enzymes, prevent fibrin deposition with anticoagulants, or inhibit fibroblastic proliferation
with steroids and antihistamines have not met with any great success.50
Measures which are recommended to decrease the likelihood of postoperative adhesion
formation, but certainly not prevent it, include: washing off glove powder; local and
systemic treatment of abdominal infection; removing all foreign matter; using warm, moist
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laparotomy pads to pack bowel; nonclosure of raw peritoneal surfaces; eliminating long,
multifilament sutures and their tails; avoiding mass ligatures; achieving complete
hemostasis; and using gentle surgical technique.50

Symptoms of Small Bowel Obstruction

The symptoms of simple, non-strangulated, small bowel obstruction include episodic
and colicky pain, nausea, vomiting and obstipation. Physical exam may be remarkable for
hyperactive, high-pitched bowel sounds, abdominal distention or mass. However, it is the
abdominal x-ray findings of dilated loops of small bowel with air-fluid levels that is the
sine qua non of small bowel obstruction.27
Many studies have documented that there is absolutely no correlation between either
temperature, pulse, abdominal wall rigidity, pain, white blood cell count, degree of nausea
or vomiting with the diagnosis of non-strangulated, small bowel obstruction.6’27’36’37
Additionally, the duration of obstructive symptoms prior to hospitalization does not
correlate with the likelihood of strangulation.6

Pathophysiology of Small Bowel Obstruction

In simple, non-strangulated small bowel obstruction, distension of the bowel wall
begins immediately, although it may not become clinically evident for some time. The
distension is due to the absence of peristalsis and the resulting accumulation of ingested
material in the gut lumen. This causes additional decreases in normal intestinal absorption
and increases in fluid secretion from the intestinal mucosa secondary to osmotic forces. An
increase in trapped, swallowed air also plays a key role in distension of bowel wall.3

Early distension is not itself directly life threatening; however, the sequelae are harmful.
These include discomfort, increased difficulty with respiration and sequestration of large
volumes of fluid within the bowel lumen.
If the obstruction remains unrelieved, the small bowel will continue to distend until the
pressure within the bowel wall is equal to (or greater than) the local venous pressure. This
increase in venous pressure results in greater intestinal capillary permeability with even
further distension of bowel wall. When the intraluminal pressure of obstructed bowel
equals the local arterial pressure, oxygenated blood is prevented from reaching the segment
of obstructed bowel, causing strangulation. The strangulated bowel segment is more likely
to leak its bacterial laden contents, first microscopically through bacterial translocation and
then grossly, causing generalized abdominal sepsis. This strangulated segment of bowel is
also more likely to become completely gangrenous. Frank perforation of the bowel wall
may also occur, resulting in severe sepsis.

Early versus Delayed Small Bowel Obstruction

Two types of mechanical, postoperative small bowel obstructions are recognized by
surgeons: early and delayed. Although various definitions of early postoperative SBO have
been used, it is generally agreed to occur up to four weeks after an abdominal operation.
Delayed postoperative SBO can occur any time after 30 days from an abdominal operation.
However, the diagnosis of early postoperative SBO is not always easy. This is due to
the difficulty differentiating clinically between postoperative paralytic ileus and early
postoperative obstruction. In the early postoperative period, some of the symptoms of
SBO are in fact normal sequelae of abdominal surgery and paralytic ileus, especially
abdominal pain, nausea, distension and lack of flatus.
Despite this difficulty in clinical differentiation, most studies of early postoperative SBO
examine all patients who are within 30 days of abdominal operation, including those who

are still in the hospital and have never fully recovered gastrointestinal function or who are
being concomitantly treated for other medical problems.13’18’30’36-37’46 In order to
eliminate this potential bias (i.e. - incorrectly reporting postoperative ileus as early SBO), a
universally accepted definition of early postoperative small bowel obstruction should be
agreed upon. For the purposes of this study, and in an attempt to eliminate potential bias,
early postoperative SBO was defined as an obstructive event occurring in patients who
were discharged from the hospital with a functioning intestine after an abdominal
procedure, but were then re-admitted with SBO within 30 days of that same procedure.

Previous Studies of Smail Bowel Obstruction After Abdominal Surgery

Previous studies have examined both early and delayed small bowel obstruction
secondary to postoperative adhesions, but few have accurately explored the tme, at-risk
incidence of SBO following various abdominal procedures.4’14’22’25’32’34-35-36’48 These
earlier studies only reported the percentages of obstructed patients who each had a different
type of abdominal surgery. Statistically speaking, this is highly deceptive because these
numbers represent only a proportion of procedures performed among postoperative patients
with SBO, not an incidence rate of SBO. Furthermore, these percentages only represent
the relative frequency of operative procedures in a particular region at a particular time in
these obstructed patients.17
For example, finding that 40% of patients with postoperative small bowel obstruction
had previous gynecological surgery allows one to only say, statistically, that in a particular
place at a particular point in time, 40% of the patients presenting with postoperative SBO
had previous gynecological surgery. From these data, there are no statistically sound
methods to calculate an incidence rate of small bowel obstruction over time among patients
who underwent gynecological surgery.

However, if there were a cohort of patients

receiving gynecological surgery followed over time, a statistically significant incidence rate
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of small bowel obstruction could be calculated using the Kaplan-Meier product-limit
method, as discussed later.

Previous Attempts to Derive an Incidence of Small Bowel Obstruction

Over the past several decades, several studies have attempted to calculate an incidence
rate for small bowel obstruction. McEntee reported an incidence of 39.9 cases of small
bowel obstruction per 100,000 population per year.28 This number is a heterodemic ratio,
which was calculated by including all those patients with an event in the numerator and
using the size of the regional population in the denominator. Heterodemic ratios are used
in many epidemiological studies; however, this approach is inadequate for calculating a
postoperative incidence value of obstruction which is of use for a surgeon, for all the
people in the denominator are not necessarily accounted for in the numerator.17 Thus not
all the people in the denominator are necessarily at risk for obstruction nor do they receive
any type of follow-up. Additionally, the denominator is obtained from regional census
figures which may be inaccurate. The heterodemic incidence figure is not useful when
searching for an incidence rate of a specific event in a specific population.
Lewis' study of appendicitis,26 has been used to calculate the incidence of small bowel
obstruction following appendectomy.50

However, review of the original work

demonstrated that the quoted incidence of 0.2% represents only early postoperative small
bowel obstruction in patients who had not been discharged from the hospital.26 There was
no follow-up in this study whatsoever.
Melody came fairly close to calculating a statistically sound incidence rate for small
bowel obstruction following total abdominal hysterectomy. He reported a 2.8% incidence
rate of SBO among his personal series of 210 patients.29

This incidence rate was

calculated by taking the total number of patients who received follow-up and dividing by
the total number of patients who subsequently developed small bowel obstruction.

Unfortunately, the author failed to report how he obtained follov,-up data and how he
accounted for varying duration of follow-up.

Thus not all 210 patients at risk in the

denominator, may actually be accounted for in the numerator. Also, Melody failed to
clearly differentiate between early and delayed postoperative small bowel obstruction.
Sannella's calculation of postoperative small bowel obstruction following
abdominoperineal resection seems statistically sound, although he omitted vital descriptions
of his statistical methodology.42 He reported an overall incidence of small bowel
obstruction following APR of 10.8%. Additionally, he differentiated between early and
delayed small bowel obstruction.

Sannella’s study would have been stronger had he

described the exact methodology of incorporating the follow-up data. How did he account
for different duration of follow-up?

How were patients lost to follow-up handled?

Because of these shortcomings, the incidence value cannot be considered statistically
reliable.

Purpose of the Present Study

Since postoperative adhesions are the most common cause of small bowel obstruction in
developed nations, it is important to specifically examine patients with this pathology.
Moreover, with the advent of laparoscopic abdominal surgery, an in-depth study of
postoperative adhesions is highly desirable to establish baseline statistics from the pre¬
laparoscopy era. Also, with the increasing number of elective abdominal procedures in a
litigious society, concern about postoperative adhesions may increase. This study will seek
to answer several questions: What is the six year incidence of small bowel obstruction
secondary to postoperative adhesions following selected abdominal procedures? Are some
abdominal procedures more apt to cause adhesion formation and subsequent small bowel
obstruction than others? What is the morbidity and mortality of the postoperative patient

presenting with small bowel obstruction? What is the impact of the primary pathology in
obstructed patients?

Design of the Present Study

In order to accurately obtain information concerning SBO after abdominal surgery, a
longitudinal cohort study must be performed.17 That is to say, a group of patients who
underwent a specific abdominal procedure must be followed forward in time and observed
for development of obstruction.
Ideally, to find the statistically correct incidence of small bowel obstruction during a
specific duration of time, a ratio may be set up. In this ratio, the numerator includes all the
cohort patients with small bowel obstruction (i.e. - an event) and the denominator contains
all the cohort patients at risk for obstruction during a certain amount of time of observation.
However, since these cohort patients are actually each observed for various amounts of
time and are lost to follow-up at different points in time, both the numerator and
denominator must be appropriately adjusted, for final outcomes of lost patients are
unknown.
The Kaplan-Meier product-limit life table analysis adjusts the incidence ratio to account
for the various durations of follow-up and the losses to follow-up experienced within the
observed cohort.24

This method of analysis calculates the cumulative proportion of

surviving patients relative to the individual survival time for each patient. Therefore, data
from a patient who was lost to follow-up after 15 months may still be used with data from a
patient lost to follow-up after 65 months, because the Kaplan-Meier product-limit tallies
each patient at risk for an event in the denominator until he or she suffers an event or is lost
to follow-up. Therefore, Kaplan-Meier product-limit analysis accurately tabulates an
adjusted probability curve, with respect to duration of follow-up, for an obstructing event
in all patients from the observed cohort over time. Additionally, the Kaplan-Meier product-

limit calculates accurate incidence rates for small cohorts (n<10), assuming the observed
cohort is not subject to sample size bias (i.e. - the small cohort contains patients who are in
fact representative of the underlying population).
Two assumptions are made by the Kaplan-Meier product-limit analysis. These are: (1)
that patients lost to follow-up have a similar fate as those who remain in the study; and (2)
that the time period in which a patient is enrolled in the study has no independent effect on
the outcome. Both of these assumptions, as they pertain to the present study, are discussed
later.
This study design is particularly powerful in that it is homodemic, meaning each patient
in the cohort who is at risk for small bowel obstruction and thus represented in the
denominator, is accounted for in the numerator through the use of follow-up data.17 This
homodemic design eliminates any speculation about patient outcome following surgery
because each patient who is at risk for small bowel obstruction is followed over time for an
event.
Using the Kaplan-Meier product-limit analysis, it is not significant whether this study is
carried out in a retrospective or prospective fashion. This is because the study design is
homodemic and each cohort patient receives individual follow-up. Obviously, the
retrospective design allows for rapid data assessment. Potential for recall bias is eliminated
because only complete medical records are reviewed.
In the present study, the abdominal procedures selected for Kaplan-Meier product-limit
analysis for subsequent SBO include colostomy, appendectomy, cholecystectomy and
splenectomy; all of which are among the most common surgeries performed today. Total
abdominal hysterectomy, by far the most frequent gynecological operation, and vaginal
hysterectomy are also subjected to Kaplan-Meier product-limit analysis for postoperative
small bowel obstruction. Moreover, two uncommon operations, Duhamel procedure and
gastroenterostomy, are included.

Abdominoperineal resection is the only procedure

examined in the present study which is indicated solely for rectal cancer.

The Duhamel procedure is one of several surgical options which may be used for the
treatment of Hirschsprung's disease in children (congenital aganglionic megacolon). It is a
two-staged procedure: An initial colostomy is later followed by a retrorectal pull-through
procedure which perserves a partially aganglionic rectum.

Recognized complications

include progressive constipation and obstipation secondary to anterior pouch formation,
fecal impaction and colonic spurs.41
Therefore, the present study represents the first application of Kaplan-Meier productlimit analysis to generate incidence rates for postoperative small bowel obstruction
following selected abdominal procedures.

Additionally, a descriptive analysis of the

postoperative cohort with small bowel obstruction will allow comparison with previous
studies.
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Cohort Parameters

A surgical cohort of patients at Yale-New Haven Hospital was created which included
all those patients who underwent any one of the 86 specified, primary abdominal
procedures listed in Table II during fiscal year 1986 (September 30, 1985 through October
1, 1986) and who were then discharged alive from the hospital.

These patients were

identified through a computer search of a data base in the Department of Quality Assurance
at Yale-New Haven Hospital which recorded all operative procedures according to the
International Classification of Diseases - Ninth Revision (ICD-9)23 code since fiscal year
1986.

All of those cohort patients who returned to Yale-New Haven Hospital with a

subsequent admitting diagnosis code of small bowel obstruction from fiscal year 1986
through fiscal year 1991 (September 30, 1985 through October 1, 1991) were then
identified by an additional computer search of admitting ICD-9 codes. The complete
medical records of cohort patients with small bowel obstruction were then manually
reviewed.
The admitting diagnosis of small bowel obstruction was based upon a combination of
history (pain, nausea, vomiting, obstipation), physical exam (bowel sounds, abdominal
distention, mass) and abdominal x-ray findings (dilated loops of small bowel, air-fluid
levels). Not every patient had all of the criteria for small bowel obstruction; however, all
patients had sufficient radiologic evidence of small bowel obstruction in combination with a
significant number of history and physical exam findings. Patients without a discharge
diagnosis of SBO were excluded from the study.
Patients with small bowel obstruction secondary to incarcerated hernia or mesenteric
vascular disease were not included in this study. Furthermore, patients from the initial

surgical cohort who developed small bowel obstruction at Yale New Haven Hospital
during a subsequent hospitalization for an admitting diagnosis other than SBO, were
omitted from this study in order to eliminate possible bias in diagnosis and treatment of
obstruction with concomitant, underlying disease. Patients from the cohort who were
transferred from other hospitals with small bowel obstruction were also excluded to
eliminate the bias of an outside work-up and partial treatment. Patients with the admitting
diagnoses of partial small bowel obstruction, intermittent small bowel obstruction, pseudo¬
obstruction (Ogilvie's syndrome), large bowel obstruction, fecal impaction, paralytic ileus
or abdominal pain were eliminated from the study. No patients were rejected from this
study on the basis of age or sex. Any patient with an incomplete medical record was
disqualified.
Information garnered from the medical records included: birth date; sex; race; any
history of abdominal surgery prior to entering the cohort; date of abdominal procedure
indexing the patient as a member of the surgical cohort; type of indexing abdominal
procedure performed; indication for indexing procedure; length of procedure; wound
classification; dates of subsequent abdominal procedures; types of subsequent abdominal
procedures; length of subsequent procedures; wound classifications of subsequent
procedures; date of first small bowel obstruction; type of medical and/or surgical treatment
for small bowel obstruction; duration of medical and/or surgical treatment for small bowel
obstruction; evidence of cancer recurrence, if applicable; number of subsequent small
bowel obstructions and treatment.
Cohort patients who returned to Yale-New Haven Hospital with an admitting diagnosis
of small bowel obstruction within 30 days of their most recent abdominal procedure were
defined as having early mechanical SBO.
Cohort patients were identified as cancer patients if the indication for their index
abdominal procedure was treatment of cancer or if subsequent development of cancer
required abdominal surgery. Patients receiving palliative procedures for cancer were

excluded from this study.

Information regarding cancer histology and any history of

radiation therapy directed towards the abdomen was obtained from the medical records of
cancer patients. Patients who were identified as having cancer and who returned to YaleNew Haven Hospital with small bowel obstruction, were classified as having obstruction
secondary to adhesions (i.e. - cancer-free), only if at surgery to treat obstruction there was
either no evidence of cancer recurrence, or the episode of obstruction resolved in fewer
than five days of medical therapy and there was no evidence of cancer recurrence in
subsequent medical records. Otherwise, cohort patients with cancer who returned to YaleNew Haven Hospital with small bowel obstruction had their postoperative obstruction
classified as secondary to cancer.

Statistical Analysis

Statistical significance testing was performed appropriately with either the two-sample t
test for independent samples with equal variances, two-sample t test for independent
samples with unequal variances (Cochran's Method), Yates corrected chi-square test for a 2
x 2 contingency table, Fisher's exact test, and chi-square test for an R x C contingency
table.40
Life table analysis was performed using the Kaplan-Meier product-limit method24 as
calculated by BioMedical Data Processing Software. The Kaplan-Meier product-limit
calculates incidence curves over time by using follow-up data from all individuals in the
cohort, regardless of duration of follow-up. This is accomplished by first numerically
ranking all the patients in the cohort according to the increasing duration of their follow-up

(i.e. - number of months observed without an event) and noting their outcome (i.e. obstruction or loss to follow-up). The Kaplan-Meier product-limit method tabulates the
probability of an event over a certain length of time, rx by taking the product of the
cumulative proportion of cohort patients surviving a certain time increment, t\? without an
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event and multiplying by the proportion of cohort patients surviving without an event in the
current time period.24 Therefore, if the cohort size is n, and rank of the cohort patient
without small bowel obstruction relative to the duration of follow-up is r, the proportion of
patients surviving the time increment, t\, without an event is [(n-r)/(n-r+l)]ti. Thus the
total probability of an event occurring over a time period, Pr[E(t) ], is the product of the
various proportions surviving without an event up to that current point in time, rx. This
may be expressed as:

Pr[E(t) ] = [(n-r)/(n-r+l)]tl * [(n-r)/(n-r+l)]t2 * [(n-r)/(n-r+l)]t3 *...[(n-r)/(n-r+l)]tx

The Kaplan-Meier product-limit was calculated for the following indexing abdominal
procedures: appendectomy, cholecystectomy, splenectomy, colostomy, total abdominal
hysterectomy, vaginal hysterectomy, abdominoperineal resection, Duhamel pull-through,
and gastroenterostomy. Statistical comparison of Kaplan-Meier incidence curves over time
was performed approproately using the Breslow-Cox test of significance.

Follow-Up Data

Patient follow-up data for the Kaplan-Meier life table was obtained by tracking each
patient in the surgical cohort through the use of computerized admitting diagnosis codes in
the Department of Quality Assurance, from fiscal year 1986 through fiscal year 1991, and
noting when, if at all, the patient was readmitted to Yale-New Haven Hospital. Patients
who came back to Yale-New Haven Hospital with any subsequent diagnosis or procedure
were considered to be Yale-New Haven Hospital users, up until their most recent
admission date (i.e. - no interval hospitalization elsewhere).

This date was used to

•T.
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calculate the duration of follow-up. Those patients who never returned to Yale-New Haven
Hospital after the index abdominal procedure were considered lost to follow-up.

Incidence Density

The incidence density for various abdominal procedures was calculated by dividing the
number of small bowel obstructions for a specific procedure by the total number of patientmonths of follow-up for that specific procedure and then multiplying the quotient by 1000.
The result was expressed as the number of SBOs per 1000 patient-months of follow-up.
The incidence density accounts for the three-dimensionality of the data, and profiles the
cohort, by producing a ratio of the total number of events to the total amount of follow-up
in the cohort for each abdominal procedure.

Technical Assistance

All computer programs accessing data from the Yale-New Haven Hospital data base
were designed in consultation with the Department of Quality Assurance at Yale-New
Haven Hospital. Program entry was performed by Chris Hilton of the Department of
Clinical Information. Otherwise, all work was performed by the author.
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RESULTS

Of the 3,810 patients in the postoperative cohort, 58 (1.5%) returned to Yale-New
Haven Hospital with an admitting diagnosis of small bowel obstruction.

Of these 58

postoperative patients returning with small bowel obstruction, seven (12.1%) had early
SBO and 51 (87.9%) had delayed SBO. Moreover, a total of 27 patients (46.6%) required
operation to relieve obstruction.

Twenty-six patients (44.8%) had SBO secondary to

recurrent cancer, of which seven (26.9%) required surgical intervention.

Kaplan-Meier Product-Limit Analysis

Figure I shows the survivorship curves as calculated from the Kaplan-Meier productlimit for the following procedures: appendectomy, colostomy, total abdominal
hysterectomy

(TAH),

vaginal

hysterectomy,

cholecystectomy,

splenectomy,

gastroenterostomy, Duhamel pull-through procedure and abdominoperineal resection
(APR). These curves graph the proportion of patients who survived their follow-up time
without small bowel obstruction.
Table III displays information concerning the total numbers of each procedure
performed, the total number of patients who returned for follow-up after each procedure,
the total duration of follow-up for each procedure, the total number of patients receiving
follow-up who subsequently developed SBO after each procedure, the adjusted KaplanMeier incidence rate of obstruction and the incidence density for each procedure. Both
Figure I and Table El will be discussed together in greater detail.

Appendectomy
The cohort of patients receiving follow-up after appendectomy consisted of 41 persons.
Of these, three (7.3%) had small bowel obstruction during 64 months of follow-up.

*»
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resulting in an adjusted Kaplan-Meier incidence rate of 10.7%. The incidence density for
appendectomy was 2.2 SBOs per 1000 patient-months of follow-up. Of the three patients
who developed SBO after appendectomy, two (66.7%) had perforated appendices at the
time of the index procedure.

Colostomy
There were 34 patients who received follow-up after colostomy. Of these patients,
seven (20.6%) developed small bowel obstruction during 69 months of follow-up,
resulting in an adjusted Kaplan-Meier incidence rate of 30.8%. The incidence density for
colostomy was 8.3 SBOs per 1000 patient-months of follow-up.

Five (71.4%) of the

patients returning with obstruction from this group underwent their initial colostomy for
cancer.

Total Abdominal Hysterectomy
There were 121 patients in the cohort who received follow-up after total abdominal
hysterectomy. Of these women, 14 (11.6%) developed small bowel obstruction during 70
months of follow-up, resulting in an adjusted Kaplan-Meier incidence rate of 18.2%. The
incidence density for TAH was 4.1 SBOs per 1000 patient-months of follow-up. Eight
(57.1%) of the women who presented with obstruction had their TAH for cancer.

Cholecystectomy
There were 141 patients who received follow-up after cholecystectomy. In this cohort,
three (2.1%) of the patients developed small bowel obstruction during 67 months of
follow-up, resulting in an adjusted Kaplan-Meier incidence rate of 6.4%. The incidence
density for SBO after cholecystectomy was 0.7 SBOs per 1000 patient-months of follow¬
up. Of the three patients who had SBO following cholecystectomy, one (33.3%) had a
perforated gallbladder at the time of index procedure.

Splenectomy
Twenty patients had follow-up after splenectomy.

From this group, two (10%)

developed small bowel obstruction during 65 months of follow-up, resulting in an adjusted
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Kaplan-Meier incidence rate of 11.2%. The incidence density for splenectomy was 4.1
SBOs per 1000 patient-months of follow-up. All the obstructions occurred within the first
seven months of follow-up. None of these patients had splenectomy for cancer or for
cancer-related staging.

Abdominoperineal Resection
There were nine patients who returned for follow-up after abdominoperineal resection.
From this group, one (11.1%) of the patients developed small bowel obstruction during 53
months of follow-up, resulting in an adjusted Kaplan-Meier incidence rate of 14.3%. The
incidence density for APR was 4.0 SBOs per 1000 patient-months of follow-up.

Vaginal Hysterectomy / Gastroenterostomy
No patients returned to Yale-New Haven Hospital with small bowel obstruction who
underwent either vaginal hysterectomy or gastroenterostomy. The vaginal hysterectomy
cohort was followed for 70 months and the gastroenterostomy cohort was followed for 11
months. The size of these cohorts was 15 and 8 respectively. The incidence density was
zero for both procedures.

Duhamel Procedure
There were three patients who received follow-up after Duhamel pull-through
procedure. Two (66.7%) of these patients developed small bowel obstruction during 36
months of follow-up, resulting in an adjusted Kaplan-Meier incidence rate of 66.7%. The
incidence density for the Duhamel procedure was 35.1 SBOs per 1000 patient-months of
follow-up. Of the two obstructed patients, one (50.0%) had an anastomotic leak followed
by an episode of generalized peritonitis. All of these patients were younger than 15 months
of age.
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Statistical Analysis of Kaplan-Meier Incidence Curves

When the Kaplan-Meier incidence curves for SBO following each of the nine abdominal
procedures were compared, a generalized Breslow-Cox p value < 0.00005 revealed a
definite, statistical difference.
When the incidence curves were compared between appendectomy, splenectomy and
cholecystectomy procedures (Figure II), there was a Breslow-Cox p value < 0.0134,
indicating a statistically significant difference in the rate of small bowel obstruction for
these three procedures. When only the appendectomy and cholecystectomy curves were
compared, there was a Breslow-Cox p value < 0.0277, indicating again a statistically
significant difference in the rate of small bowel obstruction. There was also a statistically
significant difference between the splenectomy and cholecystectomy obstruction curves,
with a Breslow-Cox p value < 0.0018.
When comparing the obstruction incidence curves of colostomy and TAH procedures
(Figure III), both of which included many cancer patients in the cohort, there was a
Breslow-Cox p value < 0.0662, a nearly statistical difference.
There was a Breslow-Cox p value < 0.1599 when the incidence curves of TAH and
vaginal hysterectomy were compared, suggesting a trend towards significance.

Descriptive Analysis
Demographics
Of the 58 patients returning with small bowel obstruction, 21 (36.2%) were male and
37 (63.8%) were female. Table IV shows the sex distribution relative to the cancer status
of each patient. There were 15 (46.9%) males and 17 (53.1%) females without cancer as
compared to 6 (23.1%) males and 20 (76.9%) females with cancer. The chi-square p value
(p = 0.061) demonstrated a nearly statistically significant difference between the gender
distributions for those with and without cancer.
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The average age for the group of patients returning with small bowel obstruction was
54.3 years. However, when the patients presenting with small bowel obstruction were
separated into those with and without cancer, the average age was 62.8 years and 47.3
years, respectively.

These two age distributions were statistically significant, with a

Cochran's method p value < 0.005. The age distributions for patients with and without
cancer are depicted graphically in Figures IV and V.

Surgical Histories
Table Va depicts the total number of abdominal procedures performed on obstructed
patients, both with and without cancer, prior to the indexing abdominal operation which
identified patients as members of the cohort. For patients without cancer, 17 (53.1%) had
no previous abdominal surgery, whereas 13 (40.6%) had one previous abdominal surgery
and two (6.3%) had two previous abdominal surgeries.

For patients with cancer, 13

(50.0%) had no previous abdominal surgery and 13 (50.0%) had only one previous
abdominal surgery.

Statistically, there were no significant differences between these

numbers.
Table Vb outlines the total number of subsequent abdominal procedures performed on
cancer patients and cancer-free patients since entering the cohort (excluding the indexing
procedure). Among the obstructed cancer patients, six (23.1%) underwent subsequent
abdominal surgery following their index procedure for additional resection of cancer;
whereas among the obstructed cancer-free patients, only two (6.3%) required subsequent
abdominal procedures. This difference was statistically significant, with a p value = 0.026
by the Fisher's exact test.

Of the six obstructed cancer patients, four (66.7%) had

exploratory laparotomy and debulking of tumor, one (16.7%) had colectomy, and one
(16.7%) had total gastrectomy.

Among the two obstructed cancer-free patients, both

(100.0%) had exploratory laparotomy.
The average total number of hours of surgery, including index procedure, for all
obstructed patients since entering the cohort was 3.0 hours. However, when the patients
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were separated into those with and without cancer (Table VI), the average total hours of
surgery since entering the cohort was 3.5 hours and 2.6 hours, respectively. With the p
value < 0.0005 by Cochran's method, there was a significant difference in the average total
number of hours of surgery received.

Treatment of SBO: Modality and Duration
The various modes of treatment received by patients with early SBO and delayed SBO
are outlined in Table VII. Long tube therapy was successful for 43.1% of the patients with
delayed SBO and 42.9% of the patients with early SBO.
Table VIII shows the average duration of hospitalization for patients with and without
cancer who presented with delayed SBO. There were no significant differences between
cancer patients and cancer-free patients with regard to the average length of hospitalization
when they each received the same type of treatment for obstruction. There was, however,
a statistically significant difference in duration of hospitalization between the different types
of treatment undertaken.

Although the average length of stay for immediate surgical

treatment and the average length of stay for surgery after failed long tube therapy were not
significantly different from each other, each differed from the average length of stay for
those patients who received successful long tube therapy alone (p value < 0.005).

Cancer Histology
There were 26 patients with a history of cancer who presented with small bowel
obstruction secondary to cancer. This represented 44.8% of all patients presenting with
small bowel obstruction from the postoperative cohort. Thirteen (50.0%) of these cancer
patients had a primary gynecological carcinoma, of which eight (30.8%) were ovarian
primaries and five (19.2%) were uterine primaries. Colon carcinoma accounted for 10
(38.5%) of the cancer patients who presented with small bowel obstruction. Two (7.7%)
of the cancer patients with SBO had gastric cancer. Lymphoma caused one (3.8%) of the
patients with cancer to return with small bowel obstruction (Table IX).
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Early versus Delayed SBO and Most Recent Abdominal i’rocedure
Table X records the type of small bowel obstruction for patients with and without
cancer. Of those patients without cancer, 25 (78.1%) of the patients had delayed small
bowel obstruction and seven (21.9%) had early small bowel obstruction. Of those patients
with cancer, all 26 (100.0%) of the patients had delayed small bowel obstruction and none
(0.0%) had early small bowel obstruction. There were no significant differences between
these figures.
Of those patients who had early small bowel obstruction, three (42.9%) had a
preceeding colectomy; three (42.9%) had a preceeding exploratory laparotomy; and one
(14.3%) had a preceeding total abdominal hysterectomy (Table XI).
Table XII shows the most recent abdominal procedure performed on patients both with
and without cancer who presented with delayed small bowel obstruction. For patients
without cancer, five (20.0%) had colon surgery; four (16.0%) had total abdominal
hysterectomy; three (12.0%) had cholecystectomy; two (8.0%) had exploratory
laparotomy; two (8.0%) had appendectomy; two (8.0%) had splenectomy; and one (4.0%)
had gastrectomy.

For patients with cancer, nine (34.6%) had colon surgery; seven

(26.9%) had total abdominal hysterectomy; four (15.4%) had exploratory laparotomy; and
two (7.7%) had gastrectomy. Statistically, there were no differences between these two
groups.

Mortality
There were no in-hospital deaths among the patients presenting with small bowel
obstruction in this study; thus a mortality rate of 0.0%. However, six (10.3%) of the
patients with SBO were discharged to Hospice in terminal condition. All six patients with
terminal obstruction originally presented with delayed small bowel obstruction and had a
history of cancer. These six patients constituted 23.1% of all patients with cancer in this
study.

Four (66.7%) of the patients discharged to Hospice had ovarian cancer; one

(16.7%) had uterine cancer; and one (16.7%) had colon cancer.
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History of Abdominal Radiation Therapy
Among the cancer patients returning with small bowel obstruction, ten (38.5%) had
some form of radiation therapy directed towards the abdomen prior to the first small bowel
obstruction.

Multiple Obstructions
Of all patients returning with small bowel obstruction from the postoperative cohort, 13
(22.4%) developed multiple obstructions over time.

Of these patients who developed

multiple obstructions, ten (76.9%) had a history of cancer, of which five (38.5%) had an
additional history significant for radiation therapy.

The remaining three (23.1%) patients

who presented multiple times with SBO each had total abdominal hysterectomies with no
history of cancer.

30

DISCUSSION

This study represents the first time that Kaplan-Meier product-limit analysis has been
applied to the study of postoperative small bowel obstruction. By retrospectively defining
a postoperative surgical cohort and following the group forward in time, observing for
small bowel obstruction, life table analysis generated incidence curves for postoperative
SBO following selected abdominal procedures.

These Kaplan-Meier product-limit

incidence curves take into account the relative duration of follow-up for each cohort patient.
Figure I depicts these incidence curves for those patients in the cohort who did not suffer
an obstructing event. From these data, incidence densities were calculated which allowed
valid comparisons of obstruction rates between the various surgical procedures.

The

novelty of this study rests in the methodology: This approach examined an old issue and
revealed new information. Previous studies had been mainly descriptive in nature by only
characterizing the obstructed group and failing to look at the entire population at risk.
Furthermore, those previous studies which quoted incidence rates, when examined closely
for statistical soundness, failed to be consistent in statistical approach.

Strengths of the Kaplan-Meier Methodology

The strength of the Kaplan-Meier product-limit method is demonstrated by analyzing the
data obtained in the present study using the techniques of previous studies.
For example, there were 179 appendectomies performed in fiscal year 1986 at YaleNew Haven Hospital of which 41 patients returned for follow-up and three developed SBO
over the ensuing six years (Table III). Using heterodemic techniques, this means that for
appendectomy, there were 3 SBOs per 230,000 population in the New Haven region over
six years, or 0.00022% of population per year. This is obviously a meaningless figure

r
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because not every person in the denominator is at-risk for post-appendectomy SBO nor is
there any accounting for loss to follow-up. A slightly more refined statistic, although still
quite heterodemic, is an incidence of 3 SBOs per 179 appendectomies performed, or 1.7%.
Although this figure attempts to account for only those patients at risk for post¬
appendectomy SBO, it is still of little value because it assumes that all 179 appendectomy
patients are still alive and would return exclusively to Yale-New Haven Hospital for
treatment of obstruction. This is obviously an invalid assumption. A crude estimate of the
incidence of SBO after appendectomy, which attempts to take follow-up into account, is an
incidence of 3 SBOs per 41 observed patients over six years, or 7.3%. This value actually
represents the percentage of patients receiving follow-up who become obstructed; however,
it is neither a true rate, nor does it account for varying duration of follow-up.

Using

Kaplan-Meier product-limit analysis, the incidence of obstruction, adjusted for duration of
follow-up after appendectomy, is 10.7% during 5.3 years of follow-up. This accounts for
the varying duration of follow-up in the cohort.
Thus these different statistical methods all produce "incidence rates" for postoperative
obstruction. It is only the Kaplan-Meier method, however, which accounts for loss to
follow-up and duration of follow-up in the at-risk population.

Rates of Obstruction Vary with Abdominal Procedure

Various abdominal procedures resulted in statistically different rates of small bowel
obstruction over time. Although this was suspected in earlier studies, only through cohort
data analysis could this be statistically defined. It must be noted, however, that three
procedures examined in the present study (Duhamel, APR, and gastroenterostomy) had
fewer than ten patients in each cohort. The importance of this fact is discussed in depth
later.
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Colostomy
Colostomy had an obstruction rate of 30.8% during 69 months of follow-up and an
incidence density of 8.3 SBOs per 1000 patient-months of follow-up. This means that
30.8% of the patients who underwent colostomy were obstructed by 69 months of follow¬
up.
Of those patients who presented with SBO after colostomy, 71.4% had the indexing
abdominal procedure for cancer. This implies that it was the cancer (i.e. - the indication for
the procedure), rather than the operative procedure itself, which caused patients to return
with obstruction. However, to properly resolve this issue, future studies need to divide the
entire cohort, not just those presenting with obstruction, into two additional cohorts: those
who undergo colostomy for cancer and those who undergo colostomy for other reasons
(i.e. - inflammatory bowel disease).

Then, using follow-up data for these two sub¬

cohorts, Kaplan-Meier product-limit analysis could be applied to determine the incidence
of obstruction for those undergoing colostomy both with and without cancer.
TAH / APR / Splenectomy
Total abdominal hysterectomy (TAH), abdominoperineal resection (APR) and
splenectomy were the next most obstruction-prone surgeries, with incidence rates of 18.2%
during 70 months of follow-up, 14.3% during 53 months of follow-up, and 11.2% during
65 months of follow-up, respectively. Incidence densities were 4.1, 4.0 and 4.1 SBOs per
1000 patient-months of follow-up, respectively.
These results are intriguing because whereas APR is always associated with cancer and
TAH may or may not be associated with cancer, splenectomy is usually associated with a
cancer-free state. This implies that the high incidence of obstruction associated with
splenectomy is due to some inherent adhesion formation associated with this particular type
of surgery. For example, when the spleen is dissected off of the diaphragm, a raw surface
is left where blood may tend to pool. This may predispose patients to adhesion formation.
Moreover, the situation in which splenectomy is indicated (i.e. - trauma) may predispose
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patients to adhesion formation, perhaps because the bowel is not prepped or a ruptured
viscus may be concomitantly present. Although there are certain cases where splenectomy
may be indicated for staging of cancer (e.g. - Hodgkins Disease), no such staging
procedures were included in the observed, postoperative cohort. The incidence curves for
obstruction following splenectomy (Figures I and II) also demonstrate a statistically
significant front-loaded risk, in other words, obstruction in this cohort tended to manifest
very early in comparison to other procedures.
In the present study, cohort patients who underwent TAH included patients both with
and without a history of gynecological cancer.

In fact, 57.1% of the patients who

presented with obstruction from the TAH cohort also had a history of cancer. Thus the
calculated incidence of obstruction following TAH may be somewhat inflated because the
cohort included both cancer and cancer-free patients. Future studies should separate the
entire TAH cohort, not just those presenting with obstruction, into those who underwent
TAH for cancer and those who underwent TAH for other reasons (e.g. - fibroids,
endometriosis). In this manner, a Kaplan-Meier product-limit incidence would be derived
for these two distinct groups.
As far as APR is concerned, 14.3% of the patients developed SBO after 53 months of
follow-up. Obstructions in this group of patients were secondary to recurrent cancer; not a
surprising fact given the indications for APR. This calculated incidence figure is close to
the incidence quoted by Sannella of 10.8%, although he does not describe his methodology
or duration of follow-up.42
This raises an interesting issue, for APR, which includes colostomy, in fact has a lower
rate of obstruction than isolated colostomy (14.3% during 53 months versus 30.8% during
69 months). With respect to obstruction secondary to recurrent cancer, this may be due to
better curative resection with APR. Of course, to properly resolve this issue, future studies
must subdivide the colostomy cohort into those with and without cancer as discussed
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above. Another reason for this finding may be sample size bias, for the APR cohort had
only nine pateints.
The incidence densities for TAH, APR and splenectomy were nearly equal. This implies
that although the rates of obstruction were different, given the size of each cohort and the
total amount of follow-up time, the overall density of events was similar. This is explained
by the front-loaded risk of obstruction associated with splenectomy (n=20) as compared to
the more static risk associated with TAH (n=121): Although the rates were different, over
time, the densities were similar.
Appendectomy
Many previous studies28-30’32’38’39 list appendectomy as a significant cause of small
bowel obstruction in the postoperative patient. Unfortunately, these studies lack a cohort
and incorrectly base their assumptions solely on returning patients with small bowel
obstruction rather than looking at all patients at risk. Since appendectomy is a common
procedure, studies which look only at returning patients with obstruction, and not entire atrisk populations, will assume the incidence of obstruction following appendectomy is much
higher than it truly is, because the appendectomy patients are disproportionately represented
due to the prevalence of the procedure. The present study demonstrated an incidence of
obstruction after appendectomy of 10.7% after 64 months of follow-up and an incidence
density of 2.2 SBOs per 1000 patient-months of follow-up.
Although the incidence of obstruction following appendectomy was not significantly
different from that of splenectomy (10.7% over 5.3 years versus 11.2% over 5.4 years),
the incidence density was lower (2.2 versus 4.1 SBOs per 1000 patient-months of follow¬
up). This reflects the large numbers of patients with greater duration of follow-up who
underwent appendectomy compared to splenectomy.

Thus previous studies cite

appendectomy as a significant cause of SBO only because it is a common procedure which
accordingly results in more obstructed patients, but actually its incidence of obstruction is
similar to that of splenectomy.
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Another issue raised by this study is that 66.7% of the patients with small bowel
obstruction who originally underwent appendectomy had a perforated appendix at the time
of initial procedure. This implies that the contaminated surgery associated with a perforated
abdominal viscus may in fact cause greater adhesion formation and a higher rate of
obstruction. However, to accurately explore this question, future studies must separate out
the entire appendectomy cohort, not just those presenting with obstruction, into those with
clean and those with contaminated surgery. Kaplan-Meier analysis would then allow
comparison of the obstruction incidence of these two sub-cohorts.
Cholecystectomy
Cholecystectomy had a low obstruction incidence of 6.4% during 67 months of follow¬
up with an incidence density of 0.7 SBOs per 1000 patient-months of follow-up. This
obstruction rate is significantly lower than that of colostomy, TAH, appendectomy or
splenectomy. Thus of all the common abdominal surgery performed, cholecystectomy was
the least obstruction-prone procedure in the abdomen.

Additionally, the calculated

incidence density reflects the relative dearth of obstruction given the large at-risk population
which received follow-up. This is an intriguing finding, because anatomically, the field of
dissection required to reach the gallbladder and its fossa presumably involves less direct
manipulation of bowel. It therefore implies that there is an irreducible minimum rate of
small bowel obstruction, secondary to adhesion formation, for just entering the abdomen.
Gastroenterostomy
The cohort which underwent gastroenterostomy had an incidence of obstruction equal to
0.0% during 11 months of follow-up and an incidence density of 0 SBOs per 1000 patientmonths of follow-up. This cohort, however, was not very large nor was it observed for a
long time. Although this calculated incidence of obstruction is in fact accurate for those
patients who underwent gastroenterostomy at Yale-New Haven Hospital in fiscal year
1986, given the small sample size and potential for sample size bias, whether or not this
incidence is applicable to the general gastroenterostomy population is questionable. To
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produce statistically significant results, future studies should observe more of these patients
for a greater duration of time.
Vaginal Hysterectomy
The vaginal hysterectomy cohort had an incidence of obstruction equal to 0.0% during
70 months of follow-up and an incidence density of 0 SBOs per 1000 patient-months of
follow-up. Previous studies have shown hemorrhage, vaginal cuff cellulitis, uterovaginal
fistula, vesicovaginal fistula and enterovaginal fistula to be recognized complications of
vaginal hysterectomy; however, no studies have examined the postoperative incidence of
SBO.1’20 This begs the question of whether or not vaginal hysterectomy in fact produces
fewer obstructing adhesions than total abdominal hysterectomy. Statistical comparison of
the incidence of postoperative SBO for these two hysterectomy procedures produced a p
value = 0.1599, suggesting a trend, but not proving that there is in fact a difference
between obstruction rates. This is because the number of patients receiving follow-up after
vaginal hysterectomy was too few: whereas 14 of 121 patients became obstructed
following TAH, 0 of 15 patients became obstructed following vaginal hysterectomy. To
fully answer this question, future studies must observe a larger cohort of women who
undergo vaginal hysterectomy. Additionally, a more powerful statistic would result by
separating out those women who underwent TAH and were cancer-free, and comparing
their rate of obstruction to those women who underwent vaginal hysterectomy and were
also cancer-free.
Duhamel Procedure
The present study demonstrated that the Duhamel pull-through procedure for
Hirschsprung's disease in children had the highest rate of subsequent obstruction. The
incidence rate of small bowel obstruction was 66.7% during 36 months of follow-up with
an incidence density of 35.1 SBOs per 1000 patient-months of follow-up. This incidence
density was high, implying that these obstructing events occurred during a relatively short
amount of follow-up time.
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Of interest is the particularly high obstruction rate obtained in the present study. One
reason may be the small size of the cohort which underwent the Duhamel procedure.
Unpublished data from the Section of Pediatric Surgery at Yale-New Haven Hospital
revealed three obstructions from 44 Duhamel procedures performed over the past 16
years.43 Unfortunately, these data do not include duration of follow-up for each patient
and, therefore, a true incidence rate cannot be calculated without further review. This does
demonstrate, however, that the observed cohort in the present study happened to contain
most of the children who were re-admitted to Yale-New Haven Hospital with subsequent
small bowel obstruction following Duhamel procedure. Therefore, given the small cohort
size in the present study, there may be sample size bias. Hence the calculated incidence
figure, although accurate for all patients who underwent Duhamel procedure at Yale-New
Haven Hospital in fiscal year 1986, may not be applicable to the general population who
underwent this procedure.

To appropriately address this issue, future studies should

include a greater number of observed patients in this cohort.
SanFilippo reported that 14.3% of the patients in his study who underwent the Duhamel
procedure and were then followed-up in clinic, returned with postoperative small bowel
obstruction secondary to adhesions.41

However, SanFilippo did not account for the

duration of follow-up: thus this number does not represent an actual incidence rate over
time, but rather a proportion of patients receiving follow-up who then developed
obstruction. Nevertheless, it does demonstrate that obstruction is in fact a significant risk
with this procedure.

Perhaps this is because the Duhamel procedure consists of two

separate abdominal operations, each with its own risk for adhesion formation, or perhaps
the remaining aganglionic intestine behaves differently with regard to adhesion formation.
In the present study, one of the two obstructed patients who underwent Duhamel
procedure had an anastomotic leak. This implies that postoperative contamination of the
peritoneal cavity predisposes patients to adhesion formation and subsequent obstruction.
To properly answer this question, however, future studies should separate out the entire
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Duhamel procedure cohort, not just those presenting with obstruction, into those patients
with and without postoperative anastomotic leak. Kaplan-Meier product-limit analysis
would then demonstrate whether or not a difference existed in subsequent rates of SBO
between these two groups.

Potential Shortcomings of the Kaplan-Meier Methodology

Surgeons may be initially surprised at the incidence figures for small bowel obstruction
following the various abdominal procedures as tabulated in the present study. However, to
arrive at an accurate incidence figure, rigorous calculations must be respected, for rates
derived from personal experience without regard to chart review and follow-up are subject
to recall bias.
The calculated incidences of obstruction following either the Duhamel procedure, APR
or gastroenterostomy, although accurate for cohort patients at Yale-New Haven Hospital in
fiscal year 1986, may not be representative of the general population. This is because these
cohorts had fewer than ten patients each. Although the Kaplan-Meier product-limit analysis
is accurate for such small samples, the number of patients studied may not be large enough
to guarantee an unbiased sample which is representative of the general population
undergoing these procedures. Future studies should increase the observed cohort sizes.
On the other hand, the calculated incidences of SBO for patients following either
colostomy, TAH, appendectomy or cholecystectomy were based on significantly larger
cohorts, eliminating any potential for sample size bias (greater than 30 patients each). The
cohorts which underwent vaginal hysterectomy and splenectomy both had fewer patients,
15 and 20 respectively, but nevertheless each had enough patients to create an unbiased
group. Therefore these incidence rates, although they may appear greater than expected to
surgeons, are in fact statistically sound.
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The incidence values of obstruction following colostomy and TAH are high because
cancer patients were not separated out from these cohorts prior to Kaplan-Meier analysis.
Therefore, these rates reflect both mechanical and cancerous obstruction in the cohort. To
resolve this issue, all cohort patients (not just those presenting with obstruction) need to be
individually examined for a history of cancer: this is beyond the scope of the study.
One assumption used in calculating the Kaplan-Meier product-limit, as outlined in the
Materials and Methods section, was that those patients who were subsequently re-admitted
to Yale-New Haven Hospital were in fact dedicated users of the hospital, until they went
elsewhere and were lost to follow-up. In other words, follow-up data were based on most
recent hospital admission data and discharge diagnoses.

This is a valid assumption,

because those postoperative cohort patients who returned to Yale-New Haven Hospital
demonstrated a preference for this hospital. Additionally, Yale-New Haven Hospital is not
solely a tertiary care center based on regional referrals, but rather one of only two local
hospitals.

Potential for bias in work-up, diagnosis and therapy was eliminated by

excluding all cohort patients who were diagnosed with SBO at any other hospital or were
transferred to Yale-New Haven Hospital.
It is possible that a few patients may have undergone their indexing primary procedure
at Yale-New Haven Hospital, had an obstructing event treated at an outside hospital, and
then returned to Yale-New Haven Hospital for treatment of another ailment. This subgroup
of cohort patients would not have been tabulated in the obstructed group, but would have
been counted as receiving follow-up which was free of obstruction. Despite eventual
follow-up at Yale-New Haven Hospital, there would be no way to know of their prior
obstruction.
Some might argue that basing Kaplan-Meier product-limit analysis on follow-up data
obtained from hospital re-admissions skews the analysis towards a sicker cohort of
patients. However, simple, mechanical small bowel obstruction is an independent event
which occurs only as a result of adhesion formation and subsequent band contraction.
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Thus other medical problems requiring hospital admission (e.g. - seizures, asthma, stroke,
renal failure) should not select out a biased population with regard to the incidence of
simple, mechanical SBO. This is an important assumption, for if the calculated incidence
rates of postoperative obstruction are to be applied to the general, at-risk population, all
patients lost to follow-up must possess a similar underlying incidence of SBO to the
population which received follow-up. Nevertheless, to improve the statistical strength of
this assumption, future studies should incorporate direct follow-up of all patients (i.e. letters and phone calls to contact patients in the cohort) for the calculation of Kaplan-Meier
incidence rates. If, on the other hand, the population lost to follow-up was indeed healthier
and experienced a lower rate of simple, mechanical SBO than the population which
received follow-up, then the calculated incidence rates of SBO in the present study
represent maximum values.
This study only examined nine operative procedures using the Kaplan-Meier productlimit method (appendectomy, colostomy, TAH, vaginal hysterectomy, cholecystectomy,
splenectomy, APR, Duhamel procedure and gastroenterostomy). Although this represents
many of the procedures which obstructed patients had most recently undergone, future
studies should examine Kaplan-Meier product-limit incidence rates for other procedures,
such as exploratory laparotomy, colectomy, abdominal aortic aneurysm repair and
urological procedures.
Many of the patients in the present study had quite complex surgical histories, with a
record of either abdominal surgery before entering the cohort, abdominal surgery since
entering the cohort, or both. Previous studies of small bowel obstruction failed to even
address this observation.4'6’13’14’22’25’27’37’39

In the present study, the most recent

abdominal procedure was used to calculate the Kaplan-Meier product-limit incidence.
Ideally, future studies should look at postoperative patients with previously pristine
surgical abdomens and tabulate incidence rates of SBO. These results should be compared
to those obtained in this study, in order to assess any difference in the rate of obstruction

%
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between first-time and multiple-time operated abdomens.

Furthermore, multivariate

analysis might be helpful in analyzing any additional risk for obstruction in patients who
underwent multiple abdominal procedures.
This study relied on ICD-9 codes for computer searches of the data base. These codes
were used to both (1) flag patients who received an indexing procedure into the cohort and
(2) scan for cohort patients who were re-admitted to the hospital. The ICD-9 codes for
admitting diagnoses of all patients at Yale-New Haven Hospital are entered into the data
base by personnel in the Quality Assurance Department based on the Patient Summary
Sheet filled out by attending physicians for each patient upon discharge. Additionally,
ICD-9 codes for all operative procedures are entered into the data base by personnel in the
Quality Assurance Department from daily operative records. It is therefore unlikely that the
ICD-9 codes are subject to any significant type of bias, given the method in which these
codes are entered into the data base.
The incidence rate of small bowel obstruction over time following any one of nine
abdominal procedures was calculated in this study. Thus, for example, this study now
permits surgeons to inform their patients that the risk over 64 months for obstruction after
appendectomy is 10.7% (i.e. - 10.7 patients out of 100 who received follow-up for 5.3
years after undergoing appendectomy developed obstruction at some point in time).
However, data beyond this time period does not exist.

Although the incidence of

obstruction appears to be a front-loaded risk (Figure I), with most obstructing events
occuring earlier, rather than later, the fact that the incidence curves plateau between 40 and
55 months does not mean that obstructions will no longer occur beyond that point in time.
Incidence rates cannot be extrapolated beyond the duration of follow-up because the rate of
obstruction may not be constant over time. To supply obstruction data beyond the follow¬
up time, future studies must again look at this cohort after additional follow-up time has
elapsed.
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Descriptive Analysis of Obstructed Patients

Early Small Bowel Obstruction
Several previous studies have addressed the percentage of small bowel obstructions
which occur within 30 days of surgery. Some authors quote ranges as wide as 10% - 50%
for early small bowel obstruction,50 whereas others support narrower ranges from 5% 29%.18 Laws calculated that 22.3% of the postoperative obstructions in his study were of
the early type.25 In the present study, 12.1% of the obstructions were classified as early,
adding more evidence that the lower range of these previous estimates is more accurate. Of
additional interest is that in this study, none of the early small bowel obstructions was
associated with cancer recurrence. Quan had similar findings in his study.36

Carcinoma and Mortality
Table XIII illustrates the percent of small bowel obstructions secondary to carcinoma in
several major studies, including this one. What becomes evident is not only the varying
percentage of patients who present with obstruction secondary to cancer, but the
universally high mortality rate among these obstructed cancer patients. Another interesting
fact is that although our study contains the greatest percentage of patients obstructed
secondary to cancer, none died in the hospital. This is because six of the cancer patients
(23.1%) were discharged in terminal condition and allowed to die at Hospice. In an era of
cost containment and death with dignity, this is an important issue which deserves further
review.
Overall mortality rates from previous studies among all patients presenting with small
bowel obstruction during the past century are listed in Table XIV. A sharp decrease in
mortality may be noted during the late 1930s and early 1940s. This is not due to the
introduction of antibiotics, but rather the introduction of the long intestinal tube as treatment
for obstruction. Furthermore, with better understanding of fluid balance and the use of
intravenous hydration, the mortality rates decreased even further.14 The fact that this study
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had a mortality rate of zero is significant, for it demonstrates that although small bowel
obstruction is still associated with morbidity, it may be no longer necessarily associated
with hospital mortality.

Obstructed Cancer Patients v. Obstructed Cancer-free Patients
Differences between the postoperative, obstructed, cancer population and the
postoperative, obstructed cancer-free population emerge from this study. There is nearly a
statistically significant difference (p value = 0.061) in the sex distributions between those
patients with and without cancer (Table IV).

This is due to the high number of

gynecological patients with cancer who presented with obstruction after their indexing
surgery.
Similarly, there is a statistically significant difference in the average age between those
obstructed patients with and without cancer (62.8 years and 47.3 years, respectively, p
value < 0.005). This is because the underlying population of cancer patients is, in fact,
older.
The average, obstructed, cancer patient received significantly more hours of surgery
since entering the cohort than the average, obstructed, cancer-free patient (3.5 hours and
2.6 hours, respectively, p value < 0.0005, Table VI).

Furthermore, although these

obstructed cancer patients did not have a past surgical history significantly different from
the obstructed cancer-free patients prior to entering the cohort (Table Va), the obstructed
cancer patients in fact had a significantly greater number of subsequent abdominal
procedures performed once they entered the cohort (Table Vb, p value = 0.026). The most
likely explanation is that despite similar past surgical histories, once diagnosed with cancer,
these cohort patients required both more hours of surgery for exterpative procedures and a
greater number of procedures overall for recurrence.
Data from this study illustrate that there are no statistical differences in the duration of
hospitalization for the treatment of SBO between obstructed cancer patients and obstructed
cancer-free patients (Table VIII). This implies that these two obstructed patient groups -
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those with and without cancer - are treated no differently by surgeons in regard to duration
of hospitalization. Not surprisingly, the data did show that those patients who received
successful tube therapy had a statistically shorter hospital stay than all other forms of
therapy. On the other hand, there was no statistical difference in duration of hospital stay
between those patients who underwent immediate surgery and those who underwent
surgery after failed intestinal tube therapy. These data are important as issues of cost
containment are raised by hospital administrators.
Among the cancer patients presenting with small bowel obstruction from the
postoperative cohort, 38.5% received prior radiation therapy to the abdomen. Contributing
to this high percentage may be the fact that many of the cancer patients at Yale-New Haven
Hospital received this type of treatment.

Exposure to abdominal radiation is widely

considered to increase the rate of obstruction.3’15’50 Although Helmkamp had a similar
result of 47.8%,21 future studies should assess the amount of radiation therapy received by
all cohort patients in order to perform Kaplan-Meier product-limit analysis.

Then

statistically accurate incidence rates of postoperative small bowel obstruction with and
without prior abdominal radiation therapy could be calculated. Nevertheless, these results
imply that abdominal radiation therapy is a significant risk factor for subsequent small
bowel obstruction.
Of the obstructed cancer patients, 13 (50.0%) had a gynecological cancer, ten (38.5%)
had colon cancer, two (7.7%) had gastric cancer and one (3.8%) had lymphoma (Table
IX). These results suggest that both gynecological cancer - especially ovarian and uterine
carcinomas - as well as colon cancer may produce significant obstruction despite previous
surgical management. However, to find out a statistically significant incidence rate of
obstruction for these cancers, future studies must define and follow-up a cohort of patients
with various types of cancer, who are at risk for obstruction, and apply Kaplan-Meier
product-limit analysis.
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One potential source of bias is the method in which cohort patients with cancer, who
returned obstructed, were classified as having an obstruction secondary to cancer rather
than adhesions. As outlined in the Materials and Methods section, cohort patients with a
history of cancer and who returned to Yale-New Haven Hospital obstructed, were
considered to have an obstruction secondary to adhesions only if there was either (1) no
evidence of recurrence at surgery to relieve the obstruction or (2) the obstruction resolved
in fewer than five days and there was no evidence of cancer recurrence in the medical
records. These are rigid parameters. Therefore, some cancer patients who had obstruction
secondary to adhesions, may in fact, had their obstruction incorrectly labeled as secondary
to cancer. Although methodologically sound, this might inflate the number of obstructed
patients reported as having obstruction secondary to carcinoma. This might contribute to
the high obstruction rate secondary to carcinoma, found in the present study, as compared
to previous studies (Table XIII).

Treatment of Patients with Small Bowel Obstruction
Table XV compares the treatment of postoperative patients presenting with both early
and delayed small bowel obstruction in previous studies as well as in this study. All of
these studies had a similar percentage of success with intestinal intubation in the treatment
of SBO: From 37.5% - 40.4% for cancer-free, delayed SBOs to 42.3% - 73.2% for all¬
comers with early SBOs. This implies that there is a certain, constant percentage of small
bowel obstructions which are treatable with intestinal tube therapy.

Thus it appears

reasonable that if there are no signs of intra-abdominal catastrophe, postoperative patients
with small bowel obstruction deserve a trial of hydration and intestinal tube therapy. This
is indeed standard practice. Surgical intervention is indicated only if there are signs of
intestinal strangulation or failure to revert obstruction with intubation.

Role of Perforated Viscus in Subsequent Small Bowel Obstruction
Perforation of an abdominal viscus appears to increase the risk for subsequent SBO.
This is presumably mediated by an increase in adhesion formation within a contaminated
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peritoneal cavity.3 Two of three obstructed patients who had undergone appendectomy had
perforated appendix preoperatively, one of three obstructed patients who had undergone
cholecystectomy had perforated gallbladder preoperatively, and one of two obstructed
patients who had undergone Duhamel procedure developed anastomotic leak
postoperatively. Of course true obstruction rates following peritoneal contamination cannot
be calculated from these figures, nevertheless, these numbers suggest an increased risk for
subsequent SBO exists. To settle this issue, future studies should perform Kaplan-Meier
product-limit analysis on patients with and without gross peritoneal contamination and
compare the resulting incidence rates of obstruction. Additionally, Kaplan-Meier productlimit analysis should be used to examine whether or not incidental enterotomies increase the
postoperative incidence of small bowel obstruction.

Multiple Obstructions
Of the patients returning with small bowel obstruction, 22.4% subsequently developed
multiple obstructions. Furthermore, 76.9% of these patients with multiple obstructions had
a history of cancer, with 38.5% of these patients having been exposed to prior radiation
therapy. The remaining 23.1% of the patients with multiple obstructions, although cancerfree, all had total abdominal hysterectomies.
This is an intriguing finding which should be examined in greater depth. Primarily, it
suggests that cancer is a significant risk factor for multiple events. Additionally, radiation
therapy appears to be linked with multiple obstructions; although on the other hand, it may
simply reflect a tendency to use radiation therapy among these cancer patients. To address
these issues in a proper statistical fashion, a cohort of patients with specific types of cancer
should be defined and observed over time for radiation therapy and obstruction. KaplanMeier product-limit analysis could then be applied to calculate incidence rates.
For cancer-free patients, either TAH is an operative procedure inherently associated with
multiple obstructions or there may be some intrinsic difference between patients who
experience multiple obstructions and those who do not.

Future studies undertaking

multivariate logistic analysis of the cohort could elucidate relative risk factors associated
with multiple obstructions.

Most Recent Abdominal Procedure Performed
Tables XVI and XVII compare the most recent abdominal procedure performed in
patients presenting with either early or delayed small bowel obstruction in studies from the
past 40 years. Colon and gynecological surgeries head each list as being the most recent
procedure performed on patients presenting with small bowel obstruction. However, these
percentages represent only proportions of the most recent operative procedure performed
on patients who subsequently developed obstruction. For example, although McEntee
found that 25% of the patients in his study who presented with small bowel obstruction had
previous appendectomies, this figure does not relate at all to the incidence of obstruction
following appendectomy. These types of statistics fail to account for the entire at-risk
population.

As discussed above, the only method to produce a statistically accurate

incidence rate is a cohort study that assesses all patients at risk, not just those who present
after an event.

Conclusions

This study demonstrated the power of Kaplan-Meier product-limit analysis as applied to
small bowel obstruction in postoperative patients. Through cohort analysis of all patients at
risk for SBO after selected abdominal procedures, incidence rates and incidence densities of
small bowel obstruction were obtained.

No other study has evaluated postoperative

obstruction using this statistical methodology.
In the present study, the Duhamel procedure was associated with the greatest incidence
of subsequent SBOs, 66.7% during 3.0 years of follow-up (n=3). Colostomy had the next
highest incidence of obstruction, 30.8% during 5.8 years of follow-up (n=34); total
abdominal hysterectomy with 18.2% during 5.8 years (n=121); abdominoperineal resection
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with 14.3% during 4.4 years (n=9); splenectomy with 11.2% during 5.4 years (n=20);
appendectomy with 10.7% during 5.3 years (n=41); and cholecystectomy with 6.4%
during 5.6 years (n=141). Both gastroenterostomy (n=8) and vaginal hysterectomy (n=15)
were not associated with any obstructions in this study.
It must be noted, however, that the incidence rates obtained for Duhamel procedure,
APR and gastroenterostomy are not necessarily applicable to the general population given
the small sample sizes.
This study also produced data which showed differences between obstructed cancer
patients and obstructed, cancer-free patients. These differences included average age as
well as average total hours of surgery and number of subsequent operative procedures
since entering the cohort. Differences in gender were nearly statistically significant. There
were in fact no differences between these two groups with regard to past surgical histories
or duration of hospitalization for similar treatment of SBO. For both groups, duration of
hospitalization was significantly shorter with successful intestinal intubation as treatment
for SBO. Additionally, there were no in-hospital deaths among either of these two groups,
although nearly one quarter of the obstructed cancer patients were discharged to Hospice in
terminal condition.
As laparoscopic surgical techniques improve, questions will arise as to the long term
sequelae - including the potential for postoperative adhesion formation.

This study

represents the only statistically thorough review of obstruction secondary to adhesion
formation for open abdominal procedures - including cholecystectomy and appendectomy.
Therefore this review may serve as a comparison for future studies of laparoscopic
adhesion formation and obstruction.
The present study also has significant legal applications. For the first time, statistically
accurate incidence values over time for postoperative obstruction are reported for nine
abdominal procedures, of which six are quite commonly performed. It must be stressed
that the data cannot be accurately extrapolated beyond the recorded follow-up time.

However, the reported incidence figures represent expected complications of abdominal
surgery secondary to adhesion formation.
Future applications of this methodology could answer the many issues raised
concerning postoperative bowel obstruction. Furthermore, this methodology could be
applied to a vast range of general surgical problems not yet addressed, including
obstructions secondary to wound contamination and inflammatory bowel disease.
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TABLE I
Previous Studies Concerning the Etiology of Intestinal Obstruction

Author

Gibson
Vick
Eliason
Cantor
Waldron
Coletti
Laws
Playforth
Stewardson
Chakrabarty
Bevan
Brolin
McEntee

Year

1888-1898
1925-1930
1934-1943
1950
1956
1964
1963-1972
1970
1967-1976
1968-1974 (India)
1976-1980
1976-1980
1987

Etiology of Intestinal Obstruction
Hernia

Adhesions

35%
45%
23%
8%
12%
7%
8%
23%
24%
51%

19%
7%
27%
56%
40%
91%
69%
60%
64%
10%
40%
57%
32%

-

19%
25%

Malignancy

15%
20%
-

14%
-

10%
9%
7%
8%
7%
12%
26%
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TABLE II
List of Abdominal Procedures which Index a Patient as
a Member of the Postoperative, Surgical Cohort

ICD-9
Procedure
Code

Procedure Name

Procedure
Count in
FY86

38.34
38.44
41.43
41.50
42.40
42.41
42.42
43.50
43.60
43.70
43.89
43.99
44.00
44.01
44.02
44.03
44.21
44.22
44.29
44.39
44.40
44.41
44.42
44.49
45.61
45.62
45.63
45.72
45.73
45.74
45.75
45.76
45.79
45.80
46.03
46.10
46.11
46.12
46.13
46.42
46.74
46.76
46.79
46.80
46.81
46.82
46.85
47.00
47.10

AAA w/ Anastomosis
AAA w/ Replacement
Partial Splenectomy
Total Splenectomy
Esophagectomy, NOS
Partial Esophagectomy
Total Esophagectomy
Partial Gastrectomy
Distal Gastrectomy
Billroth II
Partial Gastrectomy NOS
Total Gastrectomy
Vagotomy NOS
Truncal Vagotomy
Highly Selective Vagotomy
Selective Vagotomy NOS
Pyloroplasty, Revision
Pyloroplasty
Pyloroplasty NOS
Gastroenterostomy w/ Bypass
Suture of Peptic Ulcer
Suture of Gastric Ulcer
Suture of Duodenal Ulcer
Suture NOS
Small Bowel Resect - Trauma
Small Bowel Resection NOS
Small Bowel Resection, Total
Cecectomy
Right Hemicolectomy
Resection Transverse Colon
Left Hemicolectomy
Sigmoidectomy
Resection Large Colon NOS
Total Colectomy
Exteriorization Large Bowel
Colostomy
Temporoary Colostomy
Perm. Magnetic Colostomy
Permanent Colostomy NOS
Repair Pericolostomy Hernia
Closure Intestinal Fistula
Closure Large Intest. Fistula
Repair Intestine, other
Correct Instest. Malrotation
Manipulation of Small Bowel
Manipulation of Large Bowel
Manipulation NOS
Appendectomy
Incidental Appendectomy

8
38
1
53
3
1
3
1
5
5
13
9
14
3
1
1
0
0
12
23
2
7
12
0
0
75
1
10
67
7
23
69
43
8
4
18
3
0
74
1
7
1
8
2
2
1
0
1 79
203

CONTINUED...

TABLE II (continued)
ICD-9
Procedure
Code

Procedure Name

Procedure
Count in
FY86

47.20
48.50
48.62
48.63
48.65
50.22
50.30
50.40
50.61
50.69
51.21
51.22
52.53
52.70
53.70
53.80
53.90
54.11
54.40
54.50
54.63
54.72
54.92
54.95
54.99
65.30
65.40
65.50
65.61
66.29
66.32
66.39
68.30
68.40
68 50
68.60

Drainage Appendiceal Abscess
AP Resection of Rectum
Ant Resect Rectum, Colostomy
Ant Resect of Rectum
AP Pull Through (Duhamel)
Wedge Hepatectomy
Lobectomy of Liver
Total Hepatectomy
Repair of Liver Laceration
Hepatopexy
Partial Cholecystectomy
Total Cholecystectomy
Subtotal Pancreatectomy
Whipple Procedure
Abd Repair Diaphragm Hernia
Thx Repair Diaphragm Hernia
Repair Dphrgm Hernia, other
Exploratory Laparotomy
Excision Peritoneal Tissue
Lysis of Adhesions
Suture of Lac, Abd Wall
Repair Abd Wall, other
Removal Frgn Bdy Peritoneum
Ladd Operation
Abd Proc for Removal, other
Unil Oophorectomy
Unil. Salpingo-Oophorectomy
Bilat Oophorectomy
Bilat. Salpingo-Oophorectomy
Bilat Endoscopic Tubal Destr
Pomeroy Procedure
Female Sterilization NOS
Subtotal Abd Hysterectomy
Total Abd Hysterectomy
Vaginal Hysterectomy
Radical Abd Hysterectomy

2
16
7
10
3
5
9
3
6
1
1
388
0
4
1 1
3
4
424
115
246
2
3
2
3
16
140
112
5
345
15
160
106
3
504
92
23
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For further comment, see Discussion.
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TABLE IV
Distribution of Gender in Post-op Patients with Small Bowel Obstruction

# of patients
without Ca

Males
Females

Gender

%

# of patients
with Ca

%

1 5

46.9%

6

23.1%

1 7

53.1%

20

76.9%

p value = 0.061 by chi-square test
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TABLE Va
Total Number of Abdominal Procedures Performed on Patients Prior to Cohort Study

Total # of Abdominal
Procedures Performed
Prior to Cohort Study

Patients
without Ca

%

Patients with
Ca

%

None

1 7

53.1%

1 3

50.0%

Procedure x 1

1 3

40.6%

1 3

50.0%

Procedure x 2

2

6.3%

0

0.0%

Procedure x 3

0

0.0%

0

0.0%

%

Patients with
Ca

%

30

93.8%

20

76.9%

Procedure x 1

2

6.3%

6

23.1%

Procedure x 2

0

0.0%

0

0.0%

TABLE Vb
Total Number of Subsequent Abdominal Procedures Performed on Patients
Since Entering Cohort (Excluding Index Procedure)
Total # of Abdominal
Procedures Performed
since Entering Cohort *

Patients
without Ca

None

p value = 0.026 by Fisher's Exact Test

TABLE VI

Average Total of Hours in Surgery Per Patient Since Entering Cohort

Avg Total Hrs in

Patients
without cancer

Patients with
cancer

2.6

3.5

37

34

32

26

Surgery per Patient *
Total # of Procedures
Performed
Number of Patients

p < 0.0005 by Cochran's Method

Hospice in terminal condition.

tube therapy and were discharged to

6 additional patients from this group received

Treatment of Patients Presenting with Small Bowel Obstruction After Previous Abdominal Surgery at YNHH.
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TABLE VIII
Average Length of Hospital Stay for Postoperative SBO after More Than
30 Days from Surgery

Avg length of stay for immediate

p value

Pts without
cancer

Patients with
cancer

11.4 days

17.5 days

P value > 0.05 *

6.4 days

13.2 days

P value > 0.05**

21.3 days

20.0 days

P value > 0.05*

4.7 days

7.2 days

surgical treatment of SBO.
Avg duration of medical therapy
in those who fail intestinal tube
therapy.
Avg total length of stay for those
who require surgery after failed
tube therapy.
Avg length of stay for those with

P value > 0.05**

successful intestinal tube therapy
Avg length of stay for those who

22.5 days

are discharged to Hospice after
failed intestinal tube therapy.

* Two sample t test for independent samples with equal variances.
** Two sample t test for independent samples with unequal variances.
(Cochran's Method)
Note: P value < 0.005 by Cochran's Method when comparing "Avg length of stay
for immediate surgical treatment" to "Avg length of stay for those with
successful tube treatment" and "Avg total length of stay for those who require
surgery after failed tube therapy" to "Avg length of stay for those with
successful tube therapy" in both patients without and with cancer
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TABLE IX
Cancer Histology in Patients Presenting with Small Bowel
Obstruction and a Past Medical History Remarkable for
Surgically Treated Cancer

Number of
Patients

% of Cancer
Patients

13

50.0%

Ovarian

8

30.8%

Uterine

5

19.2%

Colon

10

38.5%

Gastric

2

7.7%

Lymphoma

1

3.8%

Cancer
Histology
Gyn Cancer
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Obstruction in Patients More Than 30 days Post-op (Delayed SBO)

Most Recent Abdominal Procedure Performed Before Small Bowel
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Small Bowel Obstruction Secondary to Cancer as Examined in Various Studies
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A Comparison of Studies in the Treatment of Patients Presenting with SBO after Previous Surgery

TABLE XVI

Earlier Studies Regarding Types of Most Recent Abdominal Procedures
Performed in Patients with Small Bowel Obstruction who are Fewer Than
30 Days Post-Op (Early SBO)

Author

Year

Study Limits

Previous
Surgery

% of pts
having
procedure

Miller

1959

Post-op SBOs
while pt still
in-house only

Colon Surg
Gyn Surg

35.7%
35.7%

Coletti

1964

SBOs within 21
days post-op
only

Colon Surg
Gyn Surg
Gastrectomy

51.1%
15.6%
4.4%

Sykes

1974

Post-op SBOs
while pt still
in-house only

Colorectal
Appendectomy
Hysterectomy

46.2%
23.1%
11.5%

Quatromoni

1980

Gyn Surg not
included. SBO
within 30 days
post-op only

Colorectal
Appendectomy
Liver/Spleen
Gastrectomy

26.8%
26.8%
17.1%
14.6%

Frykberg

1989

SBO within 30
days post-op
only

Colon Surg
Gyn Surg

38.5%
15.4%

Zbar

1991

SBO within 30
days post-op
only

Colon Surg
E Lap
TAH

42.9%
42.9%
14.3%
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TABLE XVII

Comparison of Studies Regarding Types of Most Recent Abdominal
Procedure Performed in Patients with Small Bowel Obstruction who
are More Than 30 Days Post-op (Delayed SBO)
Author

Year

Previous
Surgery

% of pts
having
procedure

Nemir

1952

Pelvic Surg
Appendectomy

29.5%
18.8%

Miller

1959

Pelvic Surg
Appendectomy
ELap

45.8%
33.3%
8.0%

Raf

1969

Appendectomy
Gyn Surg
Gastric Surg

37.8%
27.7%
7.8%

McEntee

1987

Appendectomy
Colonic Resect
Hysterectomy
Cholecystectomy

25.0%
25.0%
11.7%
5.0%

Zbar

1991

Colon Surg
TAH
ELap
Cholecystectomy
Gastrectomy

27.5%
21.6%
11.8%
5.9%
5.9%
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